These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30629447)

  • 21. Vaccinia peptides eluted from HLA-DR1 isolated from virus-infected cells are recognized by CD4+ T cells from a vaccinated donor.
    Strug I; Calvo-Calle JM; Green KM; Cruz J; Ennis FA; Evans JE; Stern LJ
    J Proteome Res; 2008 Jul; 7(7):2703-11. PubMed ID: 18507432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From crescent to mature virion: vaccinia virus assembly and maturation.
    Liu L; Cooper T; Howley PM; Hayball JD
    Viruses; 2014 Oct; 6(10):3787-808. PubMed ID: 25296112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.
    Jaraquemada D; Marti M; Long EO
    J Exp Med; 1990 Sep; 172(3):947-54. PubMed ID: 2388037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative Temporal Proteomic Analysis of Vaccinia Virus Infection Reveals Regulation of Histone Deacetylases by an Interferon Antagonist.
    Soday L; Lu Y; Albarnaz JD; Davies CTR; Antrobus R; Smith GL; Weekes MP
    Cell Rep; 2019 May; 27(6):1920-1933.e7. PubMed ID: 31067474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccinia virus requires glutamine but not glucose for efficient replication.
    Fontaine KA; Camarda R; Lagunoff M
    J Virol; 2014 Apr; 88(8):4366-74. PubMed ID: 24501408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of the
    Bravo Cruz AG; Han A; Roy EJ; Guzmán AB; Miller RJ; Driskell EA; O'Brien WD; Shisler JL
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human cytotoxic CD4+ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses.
    Mitra-Kaushik S; Cruz J; Stern LJ; Ennis FA; Terajima M
    J Immunol; 2007 Jul; 179(2):1303-12. PubMed ID: 17617623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No recognition of MHC class II+ cells infected with a vaccinia virus encoding influenza type A nucleoprotein by class II-restricted T cells.
    Freer G; Senesi S
    Immunol Lett; 1993 Jun; 36(3):305-12. PubMed ID: 8370602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Vaccinia Virus Replisome and Transcriptome Proteins by Isolation of Proteins on Nascent DNA Coupled with Mass Spectrometry.
    Senkevich TG; Katsafanas GC; Weisberg A; Olano LR; Moss B
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28747503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.
    Bounds CE; Terry FE; Moise L; Hannaman D; Martin WD; De Groot AS; Suschak JJ; Dupuy LC; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):2824-2836. PubMed ID: 28575582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of the Vaccinia Virus I2 Protein Interrupts Virion Morphogenesis, Leading to Retention of the Scaffold Protein and Mislocalization of Membrane-Associated Entry Proteins.
    Hyun SI; Weisberg A; Moss B
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
    Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
    J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary Human B Cells at Different Differentiation and Maturation Stages Exhibit Distinct Susceptibilities to Vaccinia Virus Binding and Infection.
    Shepherd N; Lan J; Li W; Rane S; Yu Q
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of deep XLMS with deep learning reveals an ordered rearrangement and assembly of a major protein component of the vaccinia virion.
    Mirzakhanyan Y; Jankevics A; Scheltema RA; Gershon PD
    mBio; 2023 Oct; 14(5):e0113523. PubMed ID: 37646531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.
    Terajima M; Cruz J; Leporati AM; Demkowicz WE; Kennedy JS; Ennis FA
    Hum Immunol; 2006 Jul; 67(7):512-20. PubMed ID: 16829305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus.
    Maa JS; Esteban M
    J Virol; 1987 Dec; 61(12):3910-9. PubMed ID: 3316708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles.
    Chung CS; Chen CH; Ho MY; Huang CY; Liao CL; Chang W
    J Virol; 2006 Mar; 80(5):2127-40. PubMed ID: 16474121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
    Raafat N; Sadowski-Cron C; Mengus C; Heberer M; Spagnoli GC; Zajac P
    Int J Cancer; 2012 Sep; 131(5):E659-69. PubMed ID: 22116674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the Cowpox Virus and Vaccinia Virus Mature Virion Proteome: Analysis of the Species- and Strain-Specific Proteome.
    Doellinger J; Schaade L; Nitsche A
    PLoS One; 2015; 10(11):e0141527. PubMed ID: 26556597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling.
    Price PJ; Torres-Domínguez LE; Brandmüller C; Sutter G; Lehmann MH
    Vaccine; 2013 Sep; 31(39):4231-4. PubMed ID: 23523404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.